What is AHCO's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.85B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for AHCO?

P/E (TTM) is n/a and 52-week range is $5.21 to $13.43 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s AHCO figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for AHCO?

The company profile lists revenue (TTM) near $3.23B, net income (TTM) near $-22.80B, EPS (TTM) near $-1.68 when available from the market-data feed. Figures are informational and may lag live markets.

Where is Adapthealth Corp based, and what identifiers does Chartloom list?

The company context section lists headquarters in Conshohocken, Pennsylvania, US, 136.1M shares outstanding, ISIN US00653Q1022 when available from company profile and filing metadata.

Please enable JavaScript to continue using this application.

Adapthealth Corp (AHCO) Stock Analysis, Quote & Company Profile

Adapthealth Corp

$AHCO

Health Care · Health Care Providers & Services

IR Run Scenarios

$6.35

+1.60%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. The company is headquartered in Conshohocken, Pennsylvania and currently employs 10,900 full-time employees. The company went IPO on 2018-02-21. The firm provides a full suite of medical products and solutions designed to help patients manage chronic conditions in the home. Its product and service offerings include sleep therapy equipment, supplies, and related services (including CPAP and bi PAP services) to individuals suffering from obstructive sleep apnea; medical devices and supplies to patients for the treatment of diabetes, including continuous glucose monitors and insulin pumps; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs. The company operates in 50 states through its network of over 670 locations in 47 states.

Employees

10,900

Website

adapthealth.com/investor-relations/

IPO

2018-02-21

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)